• Bleomycin Sulfate: Advanced Protocols for DNA Damage & Fibro

  2026-06-25

  Bleomycin Sulfate (Blenoxane) is the gold-standard for inducing DNA strand breaks and modeling pulmonary fibrosis in translational research. This guide unpacks actionable protocols, highlights breakthrough findings on ATM regulation, and delivers expert troubleshooting strategies that maximize reproducibility and mechanistic insight.

• Uremic Metabolite Adsorption on Hydroxy-PEO Films: Mechanist

  2026-06-24

  This study systematically explores how uremic metabolites, including clinically relevant compounds such as 4-ethylphenyl sulfate, adsorb to hydroxy-terminated polyethylene oxide (PEO–OH) thin films. By examining the role of chain density and end-group chemistry, the research reveals that film properties and metabolite structure collectively govern adsorption, with direct implications for the design of hemocompatible biomaterials and biomarker research in renal dysfunction.

• Wortmannin: PI3K Inhibitor Workflows for Cancer and Autophag

  2026-06-23

  Wortmannin stands out as a gold-standard PI3K inhibitor, enabling precise dissection of PI3K/Akt/mTOR signaling and autophagy in cancer and immunology models. This guide translates bench-validated protocols, troubleshooting strategies, and comparative insights for researchers aiming to maximize reproducibility and impact.

• Urolithin A: New Frontiers in Mitochondrial Biogenesis and F

  2026-06-23

  Explore the role of Urolithin A in mitochondrial biogenesis and its emerging applications in fibrosis and cellular metabolism research. Discover unique protocol parameters and actionable insights for advanced assay design.

• Myriocin as a Serine Palmitoyltransferase Inhibitor: Protoco

  2026-06-22

  Myriocin empowers researchers to precisely interrogate sphingolipid metabolism and cell cycle regulation through its potent, selective inhibition of serine palmitoyltransferase. This article unpacks experimental workflows, advanced troubleshooting, and translational applications, with practical guidance rooted in the latest cardiac and cancer research.

• Fast Differentiation of HepaRG Cells for HBV and HDV Infecti

  2026-06-22

  The reference study establishes a rapid, chemically defined protocol for differentiating HepaRG cells, enabling efficient Hepatitis D virus (HDV) infection within one week—significantly accelerating in vitro virology research. This approach advances surrogate hepatocyte models but reveals limitations for Hepatitis B virus (HBV) replication, highlighting model-specific nuances for antiviral studies.

• Phosphatase Inhibitor Cocktail 1: Preserving Protein Phospho

  2026-06-21

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is a potent alkaline phosphatase inhibitor blend that preserves protein phosphorylation during sample preparation. It enables accurate phosphoproteomic analysis and downstream biochemical assays by preventing dephosphorylation artifacts. This product is validated for use with animal tissues and cultured cells in research settings.

• Carvedilol in β-Adrenergic Receptor Research: Applied Workfl

  2026-06-20

  Carvedilol’s dual antagonism and antioxidant properties set it apart for β-adrenergic and α1-adrenergic receptor research, streamlining both cardiovascular and hematopoietic workflows. This article details protocol enhancements, troubleshooting, and advanced applications, leveraging APExBIO’s rigorously validated Carvedilol (SKU B1332) and the latest reference findings.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-06-19

  This study elucidates how P/Q-type (agatoxin-IVA-sensitive) voltage-gated calcium channels mediate both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons. The findings refine our understanding of synaptic mechanisms underlying heart rate regulation and highlight the utility of selective Cav2.1 channel blockers in dissecting neurocardiac circuitry.

• Nadolol (SQ-11725) in Translational Pharmacokinetics: Advanc

  2026-06-19

  Explore how Nadolol (SQ-11725) advances cardiovascular and transporter research with a focus on its unique pharmacokinetic profile and mechanistic depth. This article provides new perspectives for using Nadolol in translational studies, bridging recent findings and practical assay design.

• Bazedoxifene as an Antimalarial: SERMs in Drug Repurposing

  2026-06-18

  The reference study demonstrates that bazedoxifene, a third-generation selective estrogen receptor modulator, possesses potent antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum. These findings highlight the potential of clinically approved SERMs for rapid repurposing against drug-resistant malaria, with implications for both mechanistic research and translational applications.

• Topotecan HCl: Protocols and Troubleshooting in Cancer Model

  2026-06-18

  Topotecan HCl excels as a topoisomerase 1 inhibitor for precision DNA damage induction in cancer and neuroinflammation models. This article details advanced experimental workflows, actionable troubleshooting tips, and data-driven protocol enhancements to maximize antitumor efficacy and reproducibility.

• Nutlin-3a: Mechanistic Leverage and Strategy in Translationa

  2026-06-17

  This thought-leadership article explores the mechanistic and strategic dimensions of Nutlin-3a, a benchmark MDM2 inhibitor, for translational cancer researchers. Integrating recent advances in glioblastoma biology—including the regulatory role of miR-18a/ALOXE3-ferroptosis axis—and highlighting robust experimental workflows, the article provides actionable guidance for leveraging Nutlin-3a in p53 pathway studies. Drawing on authoritative references and competitive landscape analysis, it articulates how Nutlin-3a from APExBIO enables researchers to bridge mechanistic insight with translational opportunity, while carefully outlining protocol parameters, clinical relevance, and future perspectives.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride: Enabling

  2026-06-17

  Explore how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) is revolutionizing targeted gene delivery and functional genomics. This article uniquely examines advanced nanoparticle engineering, practical protocol insights, and real-world innovations for disease applications.

• ABT-263 (Navitoclax): Precision Bcl-2 Inhibition in Cancer R

  2026-06-16

  ABT-263 (Navitoclax) is a high-affinity, orally bioavailable Bcl-2 family inhibitor used to study caspase-dependent apoptosis and targeted cancer cell removal. Its nanomolar potency against Bcl-2, Bcl-xL, and Bcl-w, along with emerging delivery strategies, establish it as a benchmark tool for apoptosis assays and senolytic research.

444 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page